• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观遗传沉默导致乳腺癌中BRMS1表达缺失。

Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.

作者信息

Metge Brandon J, Frost Andra R, King Judy A, Dyess Donna Lynn, Welch Danny R, Samant Rajeev S, Shevde Lalita A

机构信息

Department of Oncologic Sciences, USA-Mitchell Cancer Institute, University of South Alabama, 307 N. University Blvd., Mobile, AL 36688, USA.

出版信息

Clin Exp Metastasis. 2008;25(7):753-63. doi: 10.1007/s10585-008-9187-x. Epub 2008 Jun 20.

DOI:10.1007/s10585-008-9187-x
PMID:18566899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2763604/
Abstract

Breast Cancer Metastasis Suppressor 1 (BRMS1) suppresses metastasis of human breast cancer, ovarian cancer and melanoma in athymic mice. Studies have also shown that BRMS1 is significantly downregulated in some breast tumors, especially in metastatic disease. However, the mechanisms which regulate BRMS1 expression are currently unknown. Upon examination of the BRMS1 promoter region by methylation specific PCR (MSP) analysis, we discovered a CpG island (-3477 to -2214), which was found to be hypermethylated across breast cancer cell lines. A panel of 20 patient samples analyzed showed that 45% of the primary tumors and 60% of the matched lymph node metastases, displayed hypermethylation of BRMS1 promoter. Furthermore, we found a direct correlation between the methylation status of the BRMS1 promoter in the DNA isolated from tissues, with the loss of BRMS1 expression assessed by immunohistochemistry. There are several studies investigating the mechanism by which BRMS1 suppresses metastasis; however thus far there is no study that reports the cause(s) of loss of BRMS1 expression in aggressive breast cancer. Here we report for the first time that BRMS1 is a novel target of epigenetic silencing; and aberrant methylation in the BRMS1 promoter may serve as a cause of loss of its expression.

摘要

乳腺癌转移抑制因子1(BRMS1)可抑制人乳腺癌、卵巢癌和黑色素瘤在无胸腺小鼠体内的转移。研究还表明,BRMS1在一些乳腺肿瘤中显著下调,尤其是在转移性疾病中。然而,目前尚不清楚调节BRMS1表达的机制。通过甲基化特异性PCR(MSP)分析检测BRMS1启动子区域时,我们发现了一个CpG岛(-3477至-2214),在所有乳腺癌细胞系中均发现该区域存在高甲基化。对20例患者样本进行分析显示,45%的原发性肿瘤和60%的配对淋巴结转移灶中,BRMS1启动子呈现高甲基化。此外,我们发现从组织中分离的DNA中BRMS1启动子的甲基化状态,与通过免疫组织化学评估的BRMS1表达缺失之间存在直接相关性。有多项研究探讨了BRMS1抑制转移的机制;然而,迄今为止,尚无研究报道侵袭性乳腺癌中BRMS1表达缺失的原因。在此,我们首次报道BRMS1是表观遗传沉默的一个新靶点;BRMS1启动子中的异常甲基化可能是其表达缺失的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf1/2763604/ff4e2b0be45a/nihms142314f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf1/2763604/e9aed399dfca/nihms142314f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf1/2763604/98b660ce7479/nihms142314f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf1/2763604/b0e036e616a5/nihms142314f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf1/2763604/ff4e2b0be45a/nihms142314f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf1/2763604/e9aed399dfca/nihms142314f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf1/2763604/98b660ce7479/nihms142314f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf1/2763604/b0e036e616a5/nihms142314f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf1/2763604/ff4e2b0be45a/nihms142314f4.jpg

相似文献

1
Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.表观遗传沉默导致乳腺癌中BRMS1表达缺失。
Clin Exp Metastasis. 2008;25(7):753-63. doi: 10.1007/s10585-008-9187-x. Epub 2008 Jun 20.
2
[DNA methylation modification of BRMS1 in triple-negative breast cancer and its correlation with tumor metastasis].三阴性乳腺癌中BRMS1的DNA甲基化修饰及其与肿瘤转移的相关性
Zhonghua Yi Xue Za Zhi. 2017 Nov 28;97(44):3483-3487. doi: 10.3760/cma.j.issn.0376-2491.2017.44.010.
3
BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.BRMS1 转录抑制与非小细胞肺癌中的 CpG 岛甲基化和晚期病理阶段相关。
J Pathol. 2010 Jun;221(2):229-37. doi: 10.1002/path.2707.
4
Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells.原发性乳腺癌肿瘤组织和相应循环肿瘤细胞中乳腺癌转移抑制因子 1 启动子甲基化。
Mol Cancer Res. 2013 Oct;11(10):1248-57. doi: 10.1158/1541-7786.MCR-13-0096. Epub 2013 Jun 6.
5
Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.转移性黑色素瘤中骨桥蛋白水平的升高与乳腺癌转移抑制因子 1 的表观遗传沉默相关。
Oncology. 2010;78(1):75-86. doi: 10.1159/000292363. Epub 2010 Mar 6.
6
DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.循环肿瘤细胞中肿瘤抑制基因和转移抑制基因的 DNA 甲基化。
Clin Chem. 2011 Aug;57(8):1169-77. doi: 10.1373/clinchem.2011.165902. Epub 2011 Jun 23.
7
Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.循环游离 DNA 中乳腺癌转移抑制因子-1 启动子甲基化在非小细胞肺癌中提供预后信息。
Br J Cancer. 2014 Apr 15;110(8):2054-62. doi: 10.1038/bjc.2014.104. Epub 2014 Mar 18.
8
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.ARHI基因(一种印记肿瘤抑制基因)的异常甲基化和沉默,该基因在乳腺癌中功能丧失。
Cancer Res. 2003 Jul 15;63(14):4174-80.
9
Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.CXCL12 和 ESR1 启动子 CpG 岛甲基化的同步与散发性乳腺癌的不良预后相关。
BMC Cancer. 2010 Jan 28;10:23. doi: 10.1186/1471-2407-10-23.
10
Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1.RelA/p65 的磷酸化促进了 DNMT-1 向染色质的募集,并抑制了肿瘤转移抑制基因 BRMS1 的转录。
Oncogene. 2012 Mar 1;31(9):1143-54. doi: 10.1038/onc.2011.308. Epub 2011 Jul 18.

引用本文的文献

1
Targeting EMT using low-dose Teniposide by downregulating ZEB2-driven activation of RNA polymerase I in breast cancer.通过下调 ZEB2 驱动的 RNA 聚合酶 I 激活来低剂量依托泊苷靶向 EMT 治疗乳腺癌。
Cell Death Dis. 2024 May 8;15(5):322. doi: 10.1038/s41419-024-06694-7.
2
Alpha Mangostin and Cisplatin as Modulators of Exosomal Interaction of Ovarian Cancer Cell with Fibroblasts.α-倒捻子素和顺铂作为卵巢癌细胞与成纤维细胞外泌体相互作用调节剂。
Int J Mol Sci. 2022 Aug 10;23(16):8913. doi: 10.3390/ijms23168913.
3
Roles of mitochondria in the hallmarks of metastasis.

本文引用的文献

1
Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.BRMS1与ARID4A相互作用的改变会改变基因表达,但仍能抑制人乳腺癌细胞的转移。
J Biol Chem. 2008 Mar 21;283(12):7438-44. doi: 10.1074/jbc.M709446200. Epub 2008 Jan 22.
2
Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression.基因芯片分析揭示了BRMS1介导的转移抑制的潜在机制。
Clin Exp Metastasis. 2007;24(7):551-65. doi: 10.1007/s10585-007-9092-8. Epub 2007 Sep 25.
3
Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1.
线粒体在转移特征中的作用。
Br J Cancer. 2021 Jan;124(1):124-135. doi: 10.1038/s41416-020-01125-8. Epub 2020 Nov 4.
4
The isolated C-terminal nuclear localization sequence of the breast cancer metastasis suppressor 1 is disordered.乳腺癌转移抑制因子 1 的孤立 C 端核定位序列无规则。
Arch Biochem Biophys. 2019 Mar 30;664:95-101. doi: 10.1016/j.abb.2019.01.035. Epub 2019 Jan 30.
5
BRMS1 coordinates with LSD1 and suppresses breast cancer cell metastasis.BRMS1与LSD1协同作用并抑制乳腺癌细胞转移。
Am J Cancer Res. 2018 Oct 1;8(10):2030-2045. eCollection 2018.
6
Scinderin is a novel transcriptional target of BRMS1 involved in regulation of hepatocellular carcinoma cell apoptosis.Scinderin是BRMS1的一个新的转录靶点,参与调控肝癌细胞凋亡。
Am J Cancer Res. 2018 Jun 1;8(6):1008-1018. eCollection 2018.
7
Gene expression profiling and DNA methylation analyses of CTCs.循环肿瘤细胞的基因表达谱分析与DNA甲基化分析
Mol Oncol. 2016 Mar;10(3):431-42. doi: 10.1016/j.molonc.2016.01.011. Epub 2016 Feb 5.
8
Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer.DNA高甲基化导致BRMS1表达下调及其与三阴性乳腺癌转移进展的关系
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11076-83. eCollection 2015.
9
Characterization of DNA Methylation in Circulating Tumor Cells.循环肿瘤细胞中DNA甲基化的特征分析
Genes (Basel). 2015 Oct 21;6(4):1053-75. doi: 10.3390/genes6041053.
10
Epigenetic variations in breast cancer progression to lymph node metastasis.乳腺癌进展至淋巴结转移过程中的表观遗传变异
Clin Exp Metastasis. 2015 Feb;32(2):99-110. doi: 10.1007/s10585-015-9695-4. Epub 2015 Jan 28.
基于蛋白质组学的策略来阐明转移抑制基因BRMS1的分子机制。
J Proteome Res. 2007 Oct;6(10):4006-18. doi: 10.1021/pr0703167. Epub 2007 Sep 14.
4
MDA-MB-435: the questionable use of a melanoma cell line as a model for human breast cancer is ongoing.MDA-MB-435:将一种黑色素瘤细胞系用作人类乳腺癌模型的可疑用途仍在继续。
Cancer Biol Ther. 2007 Sep;6(9):1355-7. doi: 10.4161/cbt.6.9.4624. Epub 2007 Jun 23.
5
Mutator pathways unleashed by epigenetic silencing in human cancer.人类癌症中表观遗传沉默引发的突变途径。
Mutagenesis. 2007 Jul;22(4):247-53. doi: 10.1093/mutage/gem009. Epub 2007 Apr 4.
6
Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3sigma in serum of sporadic breast cancer patients.散发性乳腺癌患者血清中抑癌基因BRCA1、p16和14-3-3sigma的高甲基化
Onkologie. 2007 Feb;30(1-2):14-9. doi: 10.1159/000096892. Epub 2007 Jan 26.
7
Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.乳腺癌转移抑制因子1(BRMS1)通过消除核因子κB激活来抑制骨桥蛋白转录。
Mol Cancer. 2007 Jan 16;6:6. doi: 10.1186/1476-4598-6-6.
8
High level of messenger RNA for BRMS1 in primary breast carcinomas is associated with poor prognosis.原发性乳腺癌中BRMS1信使核糖核酸水平高与预后不良相关。
Int J Cancer. 2007 Mar 15;120(6):1169-78. doi: 10.1002/ijc.22379.
9
Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients.乳腺癌转移抑制因子1蛋白表达缺失预示着部分乳腺癌患者无病生存期缩短。
Clin Cancer Res. 2006 Nov 15;12(22):6702-8. doi: 10.1158/1078-0432.CCR-06-0635.
10
Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.乳腺癌转移抑制因子1信使核糖核酸表达降低与乳腺癌进展不良相关。
Clin Cancer Res. 2006 Nov 1;12(21):6410-4. doi: 10.1158/1078-0432.CCR-06-1347.